Levofloxacino Pensa

Levofloxacin, the active ingredient in Levofloxacino Pensa, is a fluoroquinolone antibiotic presented as an oral tablet for oral use. It treats bacterial infections such as community‑acquired pneumonia, acute bacterial sinusitis, urinary tract infections and skin infections in adult patients, and is indicated for a range of infections including acute exacerbations of chronic bronchitis and complicated urinary tract infections.

GNH USA supplies Levofloxacino Pensa as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, providing reliable sourcing, regulatory support and consistent quality for global healthcare providers.

Levofloxacino Pensa is used to treat bacterial infections across several organ systems.

- Community‑acquired pneumonia: eradicates the causative pathogens and improves respiratory function. - Acute bacterial sinusitis: clears sinus infection and relieves congestion. - Acute exacerbations of chronic bronchitis: reduces bacterial load and eases coughing. - Uncomplicated urinary tract infection: eliminates uropathogens and resolves urinary symptoms. - Complicated urinary tract infection: provides bactericidal activity against resistant organisms. - Skin and soft‑tissue infections: treats cellulitis and other bacterial skin conditions.

Levofloxacino Pensa may cause a range of adverse reactions, most of which are dose‑independent.

Common Side Effects: - Nausea: mild to moderate gastrointestinal upset. - Diarrhea: loose stools that may be self‑limiting. - Headache: transient cranial discomfort. - Dizziness: occasional vertiginous sensations. - Insomnia: difficulty initiating or maintaining sleep. - Rash: mild skin erythema or pruritus.

Serious or Rare Side Effects: - Tendon rupture or tendinitis: especially in older adults or those on corticosteroids. - QT interval prolongation: may precipitate cardiac arrhythmias. - Severe hypersensitivity reactions: including Stevens‑Johnson syndrome and toxic epidermal necrolysis. - Clostridioides difficile‑associated colitis: severe diarrhea with abdominal pain. - Peripheral neuropathy: persistent numbness or tingling. - Hepatotoxicity: elevated liver enzymes or jaundice.

Before prescribing Levofloxacino Pensa, clinicians should consider several safety measures.

- Assess renal function: adjust dosing in patients with impaired clearance. - Avoid use in patients with known hypersensitivity to fluoroquinolones. - Monitor for tendon pain: discontinue if tendinitis or tendon rupture is suspected. - Use caution in patients with cardiac arrhythmias: may prolong QT interval. - Advise patients to avoid excessive sun exposure: photosensitivity can occur. - Store at ambient temperature below 25°C: keep in the original container, protect from moisture and light.

Levofloxacino Pensa can interact with other medicines, requiring attention to avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid): - Antacids containing magnesium or aluminum: markedly decrease levofloxacin absorption. - Warfarin: may enhance anticoagulant effect and increase bleeding risk. - Other QT‑prolonging drugs: additive risk of cardiac arrhythmias.

Moderate Interactions (Monitor Closely): - Non‑steroidal anti‑inflammatory drugs (NSAIDs): may increase central nervous system side effects. - Cyclosporine: can raise levofloxacin plasma concentrations, requiring monitoring.